Reply to Chambers, P. Comment on “Huțanu et al. Low Serum Vitamin D in COVID-19 Patients Is Not Related to Inflammatory Markers and Patients’ Outcomes—A Single-Center Experience and a Brief Review of the Literature. Nutrients 2022, 14, 1998”
Open Access
Abstract
We thank Patrick Chambers for his interestKeywords
Funding Information
- George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania (10126/1/17.12.2020)
This publication has 6 references indexed in Scilit:
- Comment on Huțanu et al. Low Serum Vitamin D in COVID-19 Patients Is Not Related to Inflammatory Markers and Patients’ Outcomes—A Single-Center Experience and a Brief Review of the Literature. Nutrients 2022, 14, 1998Nutrients, 2022
- Reply to Chambers, P. Comment on “Huțanu et al. Low Serum Vitamin D in COVID-19 Patients Is Not Related to Inflammatory Markers and Patients’ Outcomes—A Single-Center Experience and a Brief Review of the Literature. Nutrients 2022, 14, 1998”Nutrients, 2022
- Low Serum Vitamin D in COVID-19 Patients Is Not Related to Inflammatory Markers and Patients’ Outcomes—A Single-Center Experience and a Brief Review of the LiteratureNutrients, 2022
- The health effects of vitamin D supplementation: evidence from human studiesNature Reviews Endocrinology, 2021
- Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19JAMA, 2021
- Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysisHealth Technology Assessment, 2019